Microbial Translocation Is Linked to a Specific Immune Activation Profile in HIV-1-Infected Adults With Suppressed Viremia.
Aged
Antiretroviral Therapy, Highly Active
Bacterial Translocation
/ drug effects
Biomarkers
/ blood
CD4-Positive T-Lymphocytes
/ immunology
CD8-Positive T-Lymphocytes
/ immunology
DNA, Bacterial
/ blood
Female
Gastrointestinal Microbiome
/ immunology
HIV Infections
/ drug therapy
HIV-1
/ drug effects
Humans
Immune System
/ immunology
Lymphocyte Activation
/ immunology
Male
Middle Aged
Viremia
/ immunology
bacterial translocation
cell activation
coagulation
endothelium
inflammation
Journal
Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960
Informations de publication
Date de publication:
2019
2019
Historique:
received:
31
05
2019
accepted:
29
08
2019
entrez:
2
10
2019
pubmed:
2
10
2019
medline:
27
10
2020
Statut:
epublish
Résumé
Persistent immune activation in virologically suppressed HIV-1 patients, which may be the consequence of various factors including microbial translocation, is a major cause of comorbidities. We have previously shown that different profiles of immune activation may be distinguished in virological responders. Here, we tested the hypothesis that a particular profile might be the consequence of microbial translocation. To this aim, we measured 64 soluble and cell surface markers of inflammation and CD4+ and CD8+ T-cell, B cell, monocyte, NK cell, and endothelial activation in 140 adults under efficient antiretroviral therapy, and classified patients and markers using a double hierarchical clustering analysis. We also measured the plasma levels of the microbial translocation markers bacterial DNA, lipopolysaccharide binding protein (LBP), intestinal-fatty acid binding protein, and soluble CD14. We identified five different immune activation profiles. Patients with an immune activation profile characterized by a high percentage of CD38+CD8+ T-cells and a high level of the endothelial activation marker soluble Thrombomodulin, presented with higher LBP mean (± SEM) concentrations (33.3 ± 1.7 vs. 28.7 ± 0.9 μg/mL,
Identifiants
pubmed: 31572392
doi: 10.3389/fimmu.2019.02185
pmc: PMC6753629
doi:
Substances chimiques
Biomarkers
0
DNA, Bacterial
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2185Informations de copyright
Copyright © 2019 Younas, Psomas, Reynes, Cezar, Kundura, Portales, Merle, Atoui, Fernandez, Le Moing, Barbuat, Moranne, Sotto, Sabatier, Fabbro, Vincent, Dunyach-Remy, Winter, Reynes, Lavigne and Corbeau.
Références
N Engl J Med. 2001 Aug 9;345(6):408-16
pubmed: 11496851
Nat Med. 2006 Dec;12(12):1365-71
pubmed: 17115046
PLoS One. 2014 May 12;9(5):e97171
pubmed: 24819230
HIV Med. 2013 Jul;14(6):354-61
pubmed: 23332095
AIDS. 2015 Jan 2;29(1):43-51
pubmed: 25387317
J Gerontol A Biol Sci Med Sci. 2012 Nov;67(11):1212-8
pubmed: 22960476
Cardiovasc Res. 2002 Oct;56(1):126-34
pubmed: 12237173
Clin Infect Dis. 2010 May 15;50(10):1387-96
pubmed: 20380565
J Acquir Immune Defic Syndr. 2013 Dec 15;64(5):425-33
pubmed: 23797689
Arthritis Rheum. 2001 Dec;44(12):2870-8
pubmed: 11762948
J Infect Dis. 2004 Feb 15;189(4):572-82
pubmed: 14767808
J Psychiatr Res. 2018 Feb;97:54-57
pubmed: 29179013
BMC Infect Dis. 2014 Sep 29;14:521
pubmed: 25266928
EBioMedicine. 2016 Jan 28;5:135-46
pubmed: 27077120
Sci Transl Med. 2013 Jul 10;5(193):193ra91
pubmed: 23843452
HIV Med. 2016 Feb;17(2):89-105
pubmed: 26452565
J Infect Dis. 2009 Apr 15;199(8):1177-85
pubmed: 19265479
AIDS. 2018 Apr 24;32(7):945-954
pubmed: 29424776
Cell Host Microbe. 2013 Sep 11;14(3):329-39
pubmed: 24034618
PLoS Pathog. 2010 Apr 08;6(4):e1000852
pubmed: 20386714
EBioMedicine. 2016 Jun;8:265-276
pubmed: 27428436
J Acquir Immune Defic Syndr. 2014 Dec 1;67(4):370-4
pubmed: 25226210
Immunol Lett. 2014 Oct;161(2):184-8
pubmed: 24487059
J Infect Dis. 2014 Oct 15;210(8):1228-38
pubmed: 24755434
Virulence. 2013 Aug 15;4(6):507-16
pubmed: 23669075
Blood. 2013 Sep 26;122(13):2282-3
pubmed: 24072848
Curr HIV/AIDS Rep. 2012 Jun;9(2):139-47
pubmed: 22528766
J Infect Dis. 2013 Aug 15;208(4):679-89
pubmed: 23687224
Mucosal Immunol. 2014 Jul;7(4):983-94
pubmed: 24399150
Microorganisms. 2017 Sep 21;5(4):null
pubmed: 28934108
PLoS Pathog. 2014 Dec 11;10(12):e1004543
pubmed: 25503054
Curr Opin HIV AIDS. 2018 Jan;13(1):73-80
pubmed: 29045252